Precision Promise (PrP) Bayesian platform trial for metastatic pancreatic cancer (mPDAC): Results of the first experimental arm, SM-88 as second line therapy.
| Autor: | Oberstein, Paul Eliezer, wang-gillam, Andrea, Varghese, Anna M., Ko, Andrew H., Hendifar, Andrew Eugene, Ocean, Allyson J., McGlothlin, Anna, Graves, Todd, Berry, Scott M., Detry, Michelle A., Fitzgerald, Mark, Bosse, Anna, Moravek, Cassadie, Feehan, Kelly, Howland, Carrie Meghann, Berry, Donald A., Simeone, Diane M., Picozzi, Vincent J. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p675-675, 117p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|